Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2851 of 6351
-
Could a Mind-Body exercise program ease scleroderma symptoms?
Symptom relief Recruiting nowThis study aims to investigate the effectiveness of BETY, an exercise approach based on the biopsychosocial model, in children and adults diagnosed with scleroderma.
Sponsor: Hacettepe University • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Can a phone app stop muscle loss in seniors?
Prevention Recruiting nowSarcopenia, characterized by muscle loss and weakness, is a major health issue among older adults and impacts mobility and quality of life. This study addresses the current lack of long-term, technology-assisted support for managing this condition at home. This randomized control…
Sponsor: HSIAO MEI LAN • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC
-
Storytelling therapy tested to ease youth mental health crisis in hong kong
Symptom relief Recruiting nowThis cluster randomized controlled trial (cRCT) aims to evaluate the effectiveness of a narrative therapy (NT) intervention in (i) reducing mental distress, depressive symptoms, and anxiety, as well as (ii) enhancing perceived control and fostering a stronger sense of self among …
Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Lung cancer drug amivantamab under Real-World microscope
Knowledge-focused Recruiting nowThe purpose of this study is to describe the clinical and health-related outcomes of amivantamab-containing regimens for the treatment of common epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer (NSCLC; most common type of lung cancer) in a real-world set…
Sponsor: Janssen Research & Development, LLC • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
New cancer drug SHR-4298 enters early human testing
Disease control Recruiting nowThis study is an open-label, multicenter Phase I/II clinical trial to evaluate the safety, tolerability and efficacy of SHR-4298 injection in patients with malignant solid tumors.
Phase 1/2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Could a modified MDMA ease autism symptoms? small trial begins
Symptom relief Recruiting nowA Phase 2A Trial of DT402 Open-Label Study in Adults with Autism Spectrum Disorder
Phase 2 • Sponsor: Definium Therapeutics US, Inc. • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Could ketamine help veterans with back pain and depression?
Symptom relief Recruiting nowThis is a pilot study to evaluate the feasibility, acceptability, and safety of ketamine infusions followed by a brief behavioral intervention in Veterans with chronic low back pain and depression.
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
New digital registry aims to catch child abuse before it's too late
Knowledge-focused Not yet recruitingThe "Sentinella" project aims to improve the early recognition and prevention of child maltreatment by creating a digital registry and education network for healthcare professionals. The study will test a new online registry built on the REDCap platform to collect standardized, a…
Sponsor: Buzzi Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
New combo drug trial aims to control hard-to-treat prostate cancer
Disease control Recruiting nowThis study will assess the safety and tolerability of valemetostat in combination with darolutamide in participants with Metastatic Castration Resistant Prostate Cancer (mCRPC).
Phase 1 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can 'Mentalization' curb teen violence? major UK trial launches
Disease control Recruiting nowThe MICA Study is a research project that has been designed to work out how helpful mentalisation based therapy is. This is a new type of support that helps young people make sense of their own behaviours and feelings, and those of others. It involves meeting regularly with a men…
Sponsor: Anna Freud • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Could a drug combo rebuild bones faster in osteoporosis?
Disease control Recruiting nowOsteoporosis is a lifelong chronic condition requiring long-term management. Conventional first-line anti-resorptive therapies often yield slow BMD improvement and may plateau after years of treatment. Recent AACE/ACE guidelines recommend anabolic agents as initial therapy in pat…
Phase 4 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New antibody drug aims to regrow hair – first human trial underway
Disease control Recruiting nowThis is a first-in-human study of ABS-201, a new investigational medicine, in healthy adult men and women. Its main purpose is to find out whether ABS-201 is safe and well tolerated, as well as to understand how the body processes it and how it affects related biological markers.…
Phase 1/2 • Sponsor: Absci Pty Ltd. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a virtual coaching program help teens with epilepsy master laundry and cooking?
Symptom relief OngoingThe goal of this clinical trial is to learn if a telehealth intervention (Surviving and Thriving in the Real World; STRW) is helpful to improve daily living skills for teens and young adults with epilepsy. It will also learn about the acceptability, feasibility, and satisfaction …
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
New eye lens could let you focus without glasses after cataract surgery
Disease control OngoingThe purpose of this clinical study is to assess safety and explore usability and effectiveness of the test product, AAL-FAIOL. This study will be conducted in Central America.
Sponsor: Alcon Research • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Family history of heart attacks? new study uses CT scans to find hidden risks
Knowledge-focused Recruiting nowThe evidence of high-risk atherosclerosis at cardiac CT (CCT) may support aggressive primary prevention treatment, reducing the risk of future cardiovascular events. Family history of coronary artery disease (CAD) is a risk factor for cardiovascular events but limited data descri…
Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
New drug Hemay181 tested in patients with advanced cancers
Disease control Recruiting nowAn open-label phase I clinical study,which enrolled subjects with advanced solid tumors who have failed to respond to adequate standard therapies or have no available effective standard therapy.
Phase 1 • Sponsor: Ganzhou Hemay Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Blood test may cut asthma attacks in half
Disease control Recruiting nowThe aim of this study is to evaluate usual care versus biomarker-directed care (using blood eosinophil counts) for the management of asthma patients in primary care setting. The study hypothesizes that BEC is a valuable biomarker that can guide asthma treatment, and result in re…
Sponsor: National Healthcare Group Polyclinics • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Protein level may predict immunotherapy success in four cancers
Knowledge-focused Recruiting now1. Background and Rationale:: Galectin-3 (Gal-3) is a β-galactoside-binding protein involved in various biological processes, including cell proliferation, apoptosis, adhesion, and immune regulation. In cancer, Gal-3 promotes tumor progression by enhancing cell survival, meta…
Sponsor: Daniel Keizman • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:04 UTC
-
Bone stimulator may speed up Athletes' return to sport after spine injury
Symptom relief Recruiting nowThis prospective study aims to investigate the effectiveness of bone stimulator therapy as adjunct treatment of spondylolysis in athletic populations. By evaluating its impact on pain reduction, functional improvement, osseous bony union and return-to-sport time, the investigator…
Sponsor: The Methodist Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Could freezing nerves beat botox for spasticity pain?
Symptom relief Recruiting nowSpasticity is an umbrella term for impairments of muscle tone and control in people with damage to the brain and spinal cord. It is highly prevalent and results in pain, stiffness, and contribute to difficulties in activities of daily living. Current treatment options are limited…
Phase 4 • Sponsor: Oxford University Hospitals NHS Trust • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC